{"id":4290,"date":"2024-06-19T11:42:12","date_gmt":"2024-06-19T11:42:12","guid":{"rendered":"https:\/\/digitaltradecenter.com\/index.php\/2024\/06\/19\/scientists-hopeful-of-game-changing-parkinsons-test-able-to-predict-condition-seven-years-before-first-symptoms\/"},"modified":"2024-06-19T11:42:12","modified_gmt":"2024-06-19T11:42:12","slug":"scientists-hopeful-of-game-changing-parkinsons-test-able-to-predict-condition-seven-years-before-first-symptoms","status":"publish","type":"post","link":"https:\/\/digitaltradecenter.com\/index.php\/2024\/06\/19\/scientists-hopeful-of-game-changing-parkinsons-test-able-to-predict-condition-seven-years-before-first-symptoms\/","title":{"rendered":"Scientists hopeful of game changing Parkinson\u2019s test able to predict condition seven years before first symptoms"},"content":{"rendered":"<div>\n<p>With help from artificial intelligence, researchers have identified a biological signature of Parkinson&#8217;s disease they hope could lead to a simple blood test for the condition at least seven years before symptoms appear.<\/p>\n<p>A predictive test for Parkinson&#8217;s could be game changing.<\/p>\n<div class=\"sdc-site-outbrain sdc-site-outbrain--AR_6\" aria-hidden=\"true\" data-component-name=\"sdc-site-outbrain\" data-target=\"\" data-widget-mapping=\"\" data-installation-keys=\"\">    <\/div>\n<p>The progressive condition affects more than 150,000 people in the UK and is currently the world&#8217;s fastest-growing neurodegenerative disorder.<\/p>\n<p>Parkinson&#8217;s is a broad spectrum of conditions, but the most common symptoms are slowness of movement, tremors, and muscle stiffness.<\/p>\n<p>There are currently no drugs that slow or stop Parkinson&#8217;s, and efforts to develop preventative treatments are hampered by the ability to know whether someone is going to develop the condition.<\/p>\n<div class=\"ad ad--teads\">        <\/div>\n<p>Like many progressive neurological conditions, by the time symptoms emerge, the damage to brain cells caused by Parkinson&#8217;s has already occurred.<\/p>\n<p>&#8220;At present, we are shutting the stable door after the horse has bolted, and we need to start experimental treatments before patients develop symptoms,&#8221; said Professor Kevin Mills at UCL Great Ormond Street Institute of Child Health, who helped develop the blood test.<\/p>\n<p>Using machine learning &#8211; a form of <strong>artificial intelligence<\/strong> &#8211; researchers from University College London and University Medical Centre in Goettingen, Sweden, screened blood samples from people with Parkinson&#8217;s and detected eight key proteins or &#8220;biomarkers&#8221; common to those with the condition.<\/p>\n<p>They then used their machine learning tool to analyse blood samples taken a decade ago from people with a sleep condition called Rapid Eye Movement Disorder, around 75% of whom go on to develop Parkinson&#8217;s.<\/p>\n<p>The AI has so far been able to correctly predict which patients went on to develop Parkinson&#8217;s and did so up to seven years before symptoms first appeared.<\/p>\n<p>&#8220;By determining eight proteins in the blood, we can identify potential Parkinson&#8217;s patients several years in advance,&#8221; said Dr Michale Bartl at UMC Goettingen.<\/p>\n<p>&#8220;This means that drug therapies could potentially be given at an earlier stage, which could possibly slow down disease progression or even prevent it from occurring.&#8221;<\/p>\n<p>The researchers have more work to do to validate the tests&#8217; accuracy and develop a version that could be easily used in a clinic.<\/p>\n<p>&#8220;If replicated in larger studies, these tests or panels may prove to be invaluable in supporting the diagnosis of Parkinson&#8217;s,&#8221; said neurologist Professor Ray Chaudhuri, at King&#8217;s College in London.<\/p>\n<p>In the short term, a test could be used to replace the invasive lumbar puncture technique currently required to confirm Parkinson&#8217;s.<\/p>\n<p>A blood test that predicts Parkinson&#8217;s years in advance may be key to accelerating clinical trials &#8211; but it&#8217;s not without ethical hurdles, says Professor Chaudhuri.<\/p>\n<p>Currently, doctors have no drugs to prevent or stop Parkinson&#8217;s &#8211; so is it right to offer people a test?<\/p>\n<p>Gary Shaughnessy was diagnosed with Parkinson&#8217;s nine years ago and recognises the dilemma.<\/p>\n<p>He said: &#8220;I hate having Parkinson&#8217;s so why would I want to know having it for one second more than is absolutely necessary?&#8221;<\/p>\n<p>However, he argues there are actions people can take to mitigate the symptoms of Parkinson&#8217;s.<\/p>\n<p>His is exercise &#8211; he&#8217;s a competitive marathon runner.<\/p>\n<p>But he also recognises, having a predictive test for Parkinson&#8217;s could be a key step towards developing new treatments.<\/p>\n<p>&#8220;If we can make progress on a cure or treatments, it may be too late from my perspective, but it we could do something for other people that would be brilliant,&#8221; he said.<\/p>\n<\/p>\n<div>This post appeared first on sky.com<\/div>\n<\/div>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>With help from artificial intelligence, researchers have identified a biological signature of Parkinson&#8217;s disease they hope could lead to a simple blood test for the condition at least seven years before symptoms appear. A predictive test for Parkinson&#8217;s could be game changing. The progressive condition affects more than 150,000 people in the UK and is <\/p>\n","protected":false},"author":1,"featured_media":4291,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":{"0":"post-4290","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-science"},"_links":{"self":[{"href":"https:\/\/digitaltradecenter.com\/index.php\/wp-json\/wp\/v2\/posts\/4290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/digitaltradecenter.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/digitaltradecenter.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/digitaltradecenter.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/digitaltradecenter.com\/index.php\/wp-json\/wp\/v2\/comments?post=4290"}],"version-history":[{"count":0,"href":"https:\/\/digitaltradecenter.com\/index.php\/wp-json\/wp\/v2\/posts\/4290\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/digitaltradecenter.com\/index.php\/wp-json\/wp\/v2\/media\/4291"}],"wp:attachment":[{"href":"https:\/\/digitaltradecenter.com\/index.php\/wp-json\/wp\/v2\/media?parent=4290"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/digitaltradecenter.com\/index.php\/wp-json\/wp\/v2\/categories?post=4290"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/digitaltradecenter.com\/index.php\/wp-json\/wp\/v2\/tags?post=4290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}